Insiders / Wilson Troy Edward

Wilson Troy Edward

CIK 1589597personinsider
Companies
3
First seen
Jan 6, 2026
Last activity
Mar 25, 2026

Companies

CompanyRoleShares heldPeak heldTradesLatest
Kura Oncology, Inc. · KURACEO435,4561,120,0003
Avidity Biosciences, Inc. · RNADirector005
Atrium Therapeutics, Inc. · RNADirector20,0001

All securities held

3 positions · latest reported per filing
CompanySecuritySharesAs of
Atrium Therapeutics, Inc.Stock Option (Right to Buy)Derivative20,000Feb 27, 2026
Kura Oncology, Inc.Common Stock435,456Mar 23, 2026
Kura Oncology, Inc.Option to purchase common stockDerivative1,120,000Jan 2, 2026

Activity

InsidersInstitutions
This person's insider trades (Form 4), across every company.
DateActionCompanyValueShares ΔPosition afterImpact
Mar 23, 2026ExerciseKURA
Kura Oncology, Inc.
Common Stock
$37.5K+6K
+1.42%
435,456
0.49% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-15K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-13K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Stock Option (Right to Buy)
-10K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Common Stock
-14K
-100.00%
0
0.00% of shares
low
Feb 27, 2026OtherRNA
Avidity Biosciences, Inc.
Common Stock
-65K
-100.00%
0
0.00% of shares
low
Mar 23, 2026ExerciseKURA
Kura Oncology, Inc.
Stock Option (Right to Buy)
+6K
0
0.00% of shares
low
Feb 27, 2026GrantRNA
Atrium Therapeutics, Inc.
Stock Option (Right to Buy)
+20K
20,000
0.12% of shares
low
Jan 2, 2026GrantKURA
Kura Oncology, Inc.
Option to purchase common stock
+1.1M
1,120,000
1.26% of shares
low